In recent trading session, Plus Therapeutics Inc (NASDAQ:PSTV) saw 0.42 million shares changing hands at last check today with its beta currently measuring 0.85. Company’s recent per share price level of $0.78 trading at -$0.11 or -12.58% at last check today assigns it a market valuation of $13.23M. That most recent trading price of PSTV’s stock is at a discount of -242.31% from its 52-week high price of $2.67 and is indicating a premium of 69.23% from its 52-week low price of $0.24. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 45.99 million shares which gives us an average trading volume of 16.05 million if we extend that period to 3-months.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Upright in the red during last session for losing -12.58%, in the last five days PSTV remained trading in the red while hitting it’s week-highest on Friday, 03/28/25 when the stock touched $0.78 price level, adding 42.63% to its value on the day. Plus Therapeutics Inc’s shares saw a change of -32.33% in year-to-date performance and have moved -48.80% in past 5-day. Plus Therapeutics Inc (NASDAQ:PSTV) showed a performance of 122.36% in past 30-days. Number of shares sold short was 0.93 million shares which calculate 0.04 days to cover the short interests.
Plus Therapeutics Inc (PSTV) estimates and forecasts
This year revenue growth is estimated to fall -16.51% from the last financial year’s standing. 4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.11M for the same. And 4 analysts are in estimates of company making revenue of 1.14M in the next quarter. Company posted 1.68M and 1.28M of sales in current and next quarters respectively a year earlier. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 46.51% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 60.68% while estimates for its earnings growth in next 5 years are of 49.80%.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Insiders are in possession of 6.02% of company’s total shares while institution are holding 3.99 percent of that, with stock having share float percentage of 4.25%. Investors also watch the number of corporate investors in a company very closely, which is 3.99% institutions for Plus Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025, the former fund manager was holding 34.43 shares of worth $26513.0 or 0.29% of the total outstanding shares. The later fund manager was in possession of 32.54 shares on Dec 31, 2024, making its stake of worth around $25056.0 in the company or a holder of 0.28% of company’s stock.
